Vera Therapeutics stockVERA
Vera Therapeutics trades at $30.14, 46.2% below its 52-week high (Dec 24, 2025). The price is below its 50- and 200-day averages, a downtrend. −40.5% year to date, +25.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.
Ratings, candles, signals and the screener for VERA — after you log in
Open the terminalFrequently asked questions about Vera Therapeutics
What is the Vera Therapeutics stock price?
At the close on Nov 5, 2026: $30.14 (−5.72% on the day). 52-week high: $56.05 on Dec 24, 2025. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Vera Therapeutics report earnings?
The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed −27% year over year, revenue 0%.
Does Vera Therapeutics pay dividends?
No, Vera Therapeutics does not pay dividends.
Where does Vera Therapeutics trade and how to buy it?
Ticker VERA, exchange Nasdaq, listed since 2021. You can buy it through a broker with access to US exchanges.
Should I buy Vera Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for VERA are in the terminal after you log in.